UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

COVID-19 in a severe eosinophilic asthmatic receiving benralizumab – a case study

The Journal of asthma, 2021-09, Vol.58 (9), p.1270-1272

2021

Volltextzugriff (PDF)

Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy

Journal of allergy and clinical immunology, 2015-05, Vol.135 (5), p.1207-1217.e11

2015

Volltextzugriff (PDF)

CD23 surface density on B cells is associated with IgE levels and determines IgE-facilitated allergen uptake, as well as activation of allergen-specific T cells

Journal of allergy and clinical immunology, 2017-01, Vol.139 (1), p.290-299.e4

2017

Volltextzugriff (PDF)

Frequent occurrence of T cell–mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments

Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.601-609.e8

2016

Volltextzugriff (PDF)

Dupilumab rapidly improves asthma control in predominantly anti‐IL5/IL5R pretreated Austrian real‐life severe asthmatics

Immunity, Inflammation and Disease, 2021-09, Vol.9 (3), p.624-627

2021

Volltextzugriff (PDF)

COVID-19 in two severe asthmatics receiving benralizumab: busting the eosinophilia myth

ERJ open research, 2020-10, Vol.6 (4), p.457

2020

Volltextzugriff (PDF)

An Observational Study to Determine the Real-Life Effectiveness of MP-AzeFlu® in Austrian Patients with Persistent Allergic Rhinitis

Drugs -- real world outcomes, 2024-06, Vol.11 (2), p.231-240

2024

Volltextzugriff (PDF)

Analysis of serum IgE reactivity profiles with microarrayed allergens indicates absence of de novo IgE sensitizations in adults

Journal of allergy and clinical immunology, 2012-12, Vol.130 (6), p.1418-1420.e4

2012

Volltextzugriff (PDF)

Skin test evaluation of a novel peptide carrier–based vaccine, BM32, in grass pollen–allergic patients

Journal of allergy and clinical immunology, 2015-10, Vol.136 (4), p.1101-1103.e8

2015

Volltextzugriff (PDF)

Recombinant allergens: What does the future hold?

Journal of allergy and clinical immunology, 2011-04, Vol.127 (4), p.860-864

2011

Volltextzugriff (PDF)

Treatment response according to small airway phenotypes: a real-life observational study

Therapeutic advances in respiratory disease, 2016-06, Vol.10 (3), p.200-210

2016

Volltextzugriff (PDF)

Persistence of IgE-associated allergy and allergen-specific IgE despite CD4+ T cell loss in AIDS

PloS one, 2014-06, Vol.9 (6), p.e97893-e97893

2014

Volltextzugriff (PDF)

The PI3-kinase/mTOR-targeting drug NVP-BEZ235 inhibits growth and IgE-dependent activation of human mast cells and basophils

PloS one, 2012-01, Vol.7 (1), p.e29925

2012

Volltextzugriff (PDF)

Placental transfer of allergen-specific IgG but not IgE from a specific immunotherapy–treated mother

Journal of allergy and clinical immunology, 2009-12, Vol.124 (6), p.1358-1360.e1

2009

Volltextzugriff (PDF)

Amino acid absorption and homeostasis in mice lacking the intestinal peptide transporter PEPT1

American journal of physiology: Gastrointestinal and liver physiology, 2011-07, Vol.301 (1), p.G128-G137

2011

Volltextzugriff (PDF)

TRICOP – A Real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD

Respiratory medicine, 2021-06, Vol.182, p.106398-106398, Article 106398

2021

Volltextzugriff (PDF)

Benralizumab rapidly improves asthma control in Austrian real‐life severe eosinophilic asthmatics

Allergy (Copenhagen), 2020-12, Vol.75 (12), p.3272-3275

2020

Volltextzugriff (PDF)

Effectiveness of mepolizumab therapy in patients with severe eosinophilic asthma: Austrian real-life data

Pulmonary pharmacology & therapeutics, 2020-10, Vol.64, p.101946-101946, Article 101946

2020

Volltextzugriff (PDF)

Improvements in patient-reported outcomes: A prospective, non-interventional study with aclidinium bromide for treatment of COPD

Respiratory medicine, 2015-05, Vol.109 (5), p.616-624

2015

Volltextzugriff (PDF)

Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms

Journal of allergy and clinical immunology, 2019-03, Vol.143 (3), p.1258-1261

2019

Volltextzugriff (PDF)

Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1

The Journal of immunology (1950), 2011-05, Vol.186 (9), p.5333-5344

2011

Volltextzugriff (PDF)

A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype

The Journal of immunology (1950), 2013-04, Vol.190 (7), p.3068-3078

2013

Volltextzugriff (PDF)

Safety, pharmacokinetics and pharmacodynamics of a novel anti-asthmatic drug, XC8, in healthy probands

Pulmonary pharmacology & therapeutics, 2019-12, Vol.59, p.101852, Article 101852

2019

Volltextzugriff (PDF)

Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy

Current treatment options in allergy, 2014, Vol.1 (1), p.91-106

2014

Volltextzugriff (PDF)

Reslizumab in an invasively ventilated patient with acute respiratory failure

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2019-11, Vol.7 (8), p.2922-2923

2019

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(56)
Berichte
(2)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

COVID-19 in a severe eosinophilic asthmatic receiving benralizumab – a case study

Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy

CD23 surface density on B cells is associated with IgE levels and determines IgE-facilitated allergen uptake, as well as activation of allergen-specific T cells

Frequent occurrence of T cell–mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments

Dupilumab rapidly improves asthma control in predominantly anti‐IL5/IL5R pretreated Austrian real‐life severe asthmatics

COVID-19 in two severe asthmatics receiving benralizumab: busting the eosinophilia myth

An Observational Study to Determine the Real-Life Effectiveness of MP-AzeFlu® in Austrian Patients with Persistent Allergic Rhinitis

Analysis of serum IgE reactivity profiles with microarrayed allergens indicates absence of de novo IgE sensitizations in adults

Skin test evaluation of a novel peptide carrier–based vaccine, BM32, in grass pollen–allergic patients

Recombinant allergens: What does the future hold?

Treatment response according to small airway phenotypes: a real-life observational study

Persistence of IgE-associated allergy and allergen-specific IgE despite CD4+ T cell loss in AIDS

The PI3-kinase/mTOR-targeting drug NVP-BEZ235 inhibits growth and IgE-dependent activation of human mast cells and basophils

Placental transfer of allergen-specific IgG but not IgE from a specific immunotherapy–treated mother

Amino acid absorption and homeostasis in mice lacking the intestinal peptide transporter PEPT1

TRICOP – A Real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD

Benralizumab rapidly improves asthma control in Austrian real‐life severe eosinophilic asthmatics

Effectiveness of mepolizumab therapy in patients with severe eosinophilic asthma: Austrian real-life data

Improvements in patient-reported outcomes: A prospective, non-interventional study with aclidinium bromide for treatment of COPD

Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms

Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1

A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype

Safety, pharmacokinetics and pharmacodynamics of a novel anti-asthmatic drug, XC8, in healthy probands

Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy

Reslizumab in an invasively ventilated patient with acute respiratory failure

Suchergebnisse filtern